Barbara Bueloni

Pilar, B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Context matters for SMYD2 in liver disease: from hepatoprotection to tumour immune escape.

Context matters for SMYD2 in liver disease: from hepatoprotection to tumour immune escape.

Journal: Gut

Published: May 24, 2026

Unveiling the role of age in MASLD development and biological process activation: Implications for translational research.

Unveiling the role of age in MASLD development and biological process activation: Implications for translational research.

Journal: Journal of physiology and biochemistry

Published: May 14, 2026

Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma.

Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma.

Journal: Molecular therapy. Oncology

Published: January 20, 2026

Epigenetic therapies in hepatocellular carcinoma: emerging clinical tools and applications.

Epigenetic therapies in hepatocellular carcinoma: emerging clinical tools and applications.

Journal: Gut

Published: July 18, 2025

RAC1 as a novel therapeutic target for acute liver failure.

RAC1 as a novel therapeutic target for acute liver failure.

Journal: JHEP reports : innovation in hepatology

Published: January 28, 2025

Epigenetic mechanisms involved in hepatocellular carcinoma development and progression.

Epigenetic mechanisms involved in hepatocellular carcinoma development and progression.

Journal: eGastroenterology

Published: January 13, 2025

Modified mesenchymal stromal cells by in vitro transcribed mRNA: a therapeutic strategy for hepatocellular carcinoma.

Modified mesenchymal stromal cells by in vitro transcribed mRNA: a therapeutic strategy for hepatocellular carcinoma.

Journal: Stem cell research & therapy

Published: December 29, 2023

Hepatic SPARC Expression Is Associated with Inflammasome Activation during the Progression of Non-Alcoholic Fatty Liver Disease in Both Mice and Morbidly Obese Patients.

Hepatic SPARC Expression Is Associated with Inflammasome Activation during the Progression of Non-Alcoholic Fatty Liver Disease in Both Mice and Morbidly Obese Patients.

Journal: International journal of molecular sciences

Published: September 02, 2023

Chromatographic Scalable Method to Isolate Engineered Extracellular Vesicles Derived from Mesenchymal Stem Cells for the Treatment of Liver Fibrosis in Mice.

Chromatographic Scalable Method to Isolate Engineered Extracellular Vesicles Derived from Mesenchymal Stem Cells for the Treatment of Liver Fibrosis in Mice.

Journal: International journal of molecular sciences

Published: May 06, 2023

Evaluation of cancer stem cells markers expression in HCC trough real-time polymerase chain reaction.

Evaluation of cancer stem cells markers expression in HCC trough real-time polymerase chain reaction.

Journal: Methods in cell biology

Published: August 11, 2022

Design of nalidixic acid‑vanadium complex loaded into chitosan hybrid nanoparticles as smart strategy to inhibit bacterial growth and quorum sensing.

Design of nalidixic acid‑vanadium complex loaded into chitosan hybrid nanoparticles as smart strategy to inhibit bacterial growth and quorum sensing.

Journal: International journal of biological macromolecules

Published: June 10, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026